日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases

对结核病及其他肺部疾病患者血液和肺部组织中的人类髓系细胞进行靶向基因表达谱分析

Kotze, Leigh Ann; van der Spuy, Gian; Leonard, Bryan; Penn-Nicholson, Adam; Musvosvi, Munyaradzi; McAnda, Shirley; Malherbe, Stephanus T; Erasmus, Mzwandile; Scriba, Thomas; Koegelenberg, Coenraad F N; Allwood, Brian W; Walzl, Gerhard; du Plessis, Nelita

Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis

利用全反式维甲酸靶向髓系来源抑制细胞作为宿主导向疗法治疗人类结核病

Leukes, Vinzeigh N; Dorhoi, Anca; Malherbe, Stephanus T; Maasdorp, Elizna; Khoury, Justine; McAnda, Shirley; Walzl, Gerhard; du Plessis, Nelita

Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response

定量18F-FDG PET-CT扫描特征与结核病治疗反应相关。

Malherbe, Stephanus T; Chen, Ray Y; Dupont, Patrick; Kant, Ilse; Kriel, Magdalena; Loxton, André G; Smith, Bronwyn; Beltran, Caroline G G; van Zyl, Susan; McAnda, Shirely; Abrahams, Charmaine; Maasdorp, Elizna; Doruyter, Alex; Via, Laura E; Barry, Clifton E 3rd; Alland, David; Richards, Stephanie Griffith-; Ellman, Annare; Peppard, Thomas; Belisle, John; Tromp, Gerard; Ronacher, Katharina; Warwick, James M; Winter, Jill; Walzl, Gerhard

Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals

对 QuantiFERON Plus 上清液中除干扰素 γ 以外的宿主生物标志物进行前瞻性评估,以期将其作为有症状个体结核病诊断的候选标志物。

Manngo, Portia M; Gutschmidt, Andrea; Snyders, Candice I; Mutavhatsindi, Hygon; Manyelo, Charles M; Makhoba, Nonjabulo S; Ahlers, Petri; Hiemstra, Andriette; Stanley, Kim; McAnda, Shirley; Kidd, Martin; Malherbe, Stephanus T; Walzl, Gerhard; Chegou, Novel N